Company

Eliksa Therapeutics

Biotechnology Research Doylestown, Pennsylvania, United States 6 employees

Employees: 6
Contacts: 1
Emails: 1
Phones: 1

www.eliksa.com LinkedIn

Eliksa Therapeutics Overview

Headquarters: Doylestown, Pennsylvania, United States
Website: www.eliksa.com
Industry: Biotechnology Research
Employees: 6
Founded: 2021
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Eliksa Therapeutics

Eliksa Therapeutics is a venture-backed biotechnology company with a proprietary cGMP production facility and a robust clinical pipeline addressing unmet medical needs in ocular and cardiovascular indications. Our lead candidate, ELK-003, is a novel multi-target biological modulating inflammation, cell recovery, and tissue healing. ELK-003 has proven to be safe and well-tolerated with 18,000+ human doses without any reported side effects.

Eliksa Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage
Phone contacts: 1; 25.0% coverage

Eliksa Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Jane Hollingsworth	Managing Partner, Militia Hill Ventures	Philadelphia, Pennsylvania, United States	Email Phone
Elizabeth Scimeca	Research Associate	Norristown, Pennsylvania, United States	View
Armen Karamanian, Md, Phd	Co-founder & CEO at Eliksa Therapeutics		View
Victoria Prieto	Operations Manager at Eliksa	Philadelphia, Pennsylvania, United States	View